Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Experimental starting date: 27 November 2013; Experimental completion date: 28 November 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study is considered to be a reliability 1 as it has been conducted according to the Assessment of Ocular Irritation Potential using the SkinEthic Reconstructed Human Corneal Epithelial Model and in compliance with GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Assessment of Ocular Irritation Potential using the SkinEthic Reconstructed Human Corneal Epithelial Model (10-Minute Exposure)
- GLP compliance:
- yes (incl. QA statement)
Test material
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- Identification: CIM-25
Batch: MB-1
Expiry Date: 31 March 2014
Storage Conditions: room temperature in the dark
Constituent 1
Test animals / tissue source
- Species:
- other: SkinEthic Reconstructed Human Corneal Epithelium Model
- Strain:
- other: Not applicable.
- Details on test animals or tissues and environmental conditions:
- Not applicable for test animals:
Human Corneal Epithelium (HCE) model supplied by SkinEthic Laboratories, Lyon, France
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- other: Not applicable.
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): Tissues were treated with 30 mg of the test item. - Duration of treatment / exposure:
- 10 minutes.
- Observation period (in vivo):
- Not applicable.
- Number of animals or in vitro replicates:
- Not applicable.
- Details on study design:
- PREPARATION OF NEGATIVE AND POSITIVE CONTROL ITEMS:
The negative control item, Solution A (defined below), was used as supplied.
The positive control itme, Sodium Dodecyl Sulphate 2% w/v, was prepared in sterile water.
Solution A Composition for 1 Liter
Na2HPO4: 0.142 g/L
Glucose: 1.802 g/L
HEPES: 7.149 g/L
KCl: 0.224 g/L
NaCl: 7.597 g/L
PRE-TEST - ASSESSMENT OF DIRECT TEST ITEM REDUCTION OF MTT:
The MTT assay, a colorimetric method of determining cell viability, is based on reduction of the yellow tetrazolium salt (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) to a blue formazan dye by mitochondrial succinate dehydrogenase in viable cells.
One limitation of the assay is possible interference of the test item with MTT. A test item may directly reduce MTT to formazan, thus mimicking dehydrogenase activity of the cellular mitochondria of viable cells. This property of the test item is only a problem, if at the time of the MTT test (after the chemical has been rinsed off) there are still sufficient amounts of the test item on or in the tissues. To identify this possible interference, the test item was checked for its ability to reduce MTT directly.
30 mg of test item was added to 1 mL of a 0.5 mg/mL MTT solution and incubated at 37°C, 5 % CO2 in air for 3 hours. Untreated MTT solution was used as a control. If the MTT solution turned blue, the test item was presumed to have reduced the MTT.
The test item was found to have the ability to directly reduce MTT and therefore the following procedure, employing freeze-killed tissues that possess no metabolic activity but absorb and bind the test item like viable tissues, was required.
In addition to the normal test procedure, the MTT reducing test item was applied to one freeze killed tissue. One freeze-killed tissue remained untreated. The untreated freeze-killed tissue demonstrates a small amount of MTT reduction due to residual reducing enzymes.
Freeze-killed tissues were prepared by placing untreated SkinEthic HCE tissues in a freezer (-14 to -30 ºC) overnight. Once killed, the tissues were stored in the freezer.
RECEIPT AND PREPARATION OF TISSUES:
On arrival, the SkinEthic HCE tissues (Day 6 cultures), were stored at room temperature prior to transferring into 24-well plates designated ‘arrival plates’ containing 300 μL of maintenance medium. It was important to ensure that there were no air bubbles present under the tissue inserts. The tissues were incubated overnight at 37°C, 5 % CO2 in air.
MAIN TEST:
Using sterile techniques, 1 mL of maintenance medium at room temperature, was dispensed into the appropriate number of wells of 6-well plates designated ‘treatment plates’. Each well was labeled with details of the treatment and the appropriate exposure time. Separate treatment plates were used for the test item, negative and positive controls to avoid the possibility of cross contamination occurring. Before treatment, the 7 Day old tissues were transferred from the ‘arrival plates’ into the wells of the ‘treatment plates’ containing the maintenance medium.
Triplicate tissues were treated with 30 mg of the test item for 10 minutes. The tissues were dosed at regular timed intervals to allow for the period taken to rinse each insert following exposure and to ensure each tissue received an equal exposure time. Triplicate tissues were treated with 30 μL of solution A to serve as negative controls and triplicate tissues were treated with 30 μL of 2 % w/v SDS to serve as positive controls. The plates were incubated at 37°C, 5 % CO2 in air during the exposure time.
At the end of the relevant exposure period, each tissue insert was removed from the well using forceps and rinsed using a wash bottle containing Dulbecco’s Phosphate Buffered Saline (DPBS) without Ca++ and Mg++. Rinsing was achieved by filling and emptying each tissue insert using a constant soft stream of DPBS to gently remove any residual test item. Excess DPBS was removed by blotting the bottom of the insert with absorbent paper. Each tissue was placed into a pre-labeled 24 well plate designated ‘holding plate’ containing 300 μL of maintenance medium (at room temperature) until all the tissues were rinsed. Following rinsing, the tissues were transferred to a pre-labeled 24 well plate designated ‘MTT Loading plate’ containing 300 μL of a 0.5 mg/mL MTT solution freshly prepared in maintenance medium. The MTT loading plate was placed into an incubator for approximately three hours at 37°C, 5 % CO2 in air.
Due to the intrinsic 'blue' color of the test item a further limitation of the assay is possible color interference with measurement of the extracted MTT. Therefore in addition to the application procedure described above, two additional test item treated tissues and one additional color correction negative control tissue (Solution A) were treated to evaluate possible interference. These tissues followed the same treatment steps as the viable tissues except for the MTT step where MTT incubation is replaced by incubation with fresh maintenance medium for the color correction tissues.
At the end of the incubation period the inserts were rinsed twice with phosphate buffered saline and blotted on absorbent paper to remove residual MTT solution and transferred to a pre-labeled 24 well plate designated ‘MTT extraction plate’ containing 0.75 mL of isopropanol in each of a sufficient number of wells. An extra 0.75 mL of isopropanol was added onto each tissue and the plate sealed to prevent isopropanol evaporation. The plate was wrapped in aluminum foil (to protect from light) and allowed to stand overnight at room temperature to extract the formazan crystals out of the tissue.
At the end of the extraction period, each tissue insert was pierced with a pipette fitted with a 1000 μL tip and the extraction solution forced vigorously up and down through the tissue insert until a homogeneous solution was obtained. The empty inserts were discarded. For each tissue triplicate 200 μL samples were transferred to the appropriate wells of a pre-labeled 96-well plate. 200 μL of isopropanol alone was added to three wells designated as ‘blanks’. The optical density was measured (quantitative measurement of tissue viability) at 562nm (OD562) using the Anthos 2001 microplate reader.
Results and discussion
In vivo
Results
- Irritation parameter:
- other: Relative Mean Viability (%)
- Basis:
- mean
- Remarks:
- (Test item)
- Time point:
- other: 10 minutes
- Score:
- 99.7
- Remarks on result:
- other: Non-irritant.
- Irritant / corrosive response data:
- Assessment of Eye Irritation Potential:
The individual and mean OD562 values and mean viabilities for each treatment group are given in Table 1.
The relative mean viability of the test item treated tissues after a 10 Minute exposure period was 99.7%. - Other effects:
- Assessment of Direct Test Item Reduction of MTT:
The MTT solution containing the test item turned purple which indicated that the test item directly reduced MTT and therefore the MTT viability assay was performed in parallel on viable and freeze-killed tissues. However, the results obtained showed a negligible degree of interference due to direct reduction of MTT occurred. It was therefore considered unnecessary to use the results of the freeze-killed tissues for quantitative correction of results or for reporting purposes.
Color Interference Check:
It was decided that color correction tissues should be incorporated into the testing due to the intrinsic 'dark blue' color of the test item. The color correction tissues would be used to measure any staining, adherence or absorbed test item into the tissue that may have caused interference with the optical density measurements.
Therefore in addition to the normal dosing procedure, an additional two tissues were treated with the test item. A further tissue was treated with the negative control item, solution A, for correcting background color. These additional groups were not placed into MTT but into maintenance medium for the equivalent MTT exposure of 3 hours.
The optical density results indicated that negligible color interference had occurred due to the colored test item and therefore the additional tissues were not required for correction of the results.
Any other information on results incl. tables
Table 1: Assessment of Eye Irritation Potential - Viability of HCE Tissues
Item |
OD562 of Individual Tissue |
Mean OD562 |
Relative Mean Viability (%) |
Negative Control |
1.075 |
1.098 |
100* |
1.085 |
|||
1.135 |
|||
Positive Control |
0.177 |
0.146 |
13.3 |
0.127 |
|||
0.135 |
|||
Test Item |
1.108 |
1.095 |
99.7 |
1.098 |
|||
1.080 |
* = The mean viability of the negative control tissues is set at 100%
Applicant's summary and conclusion
- Interpretation of results:
- not irritating
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- According to the study plan followed the test item was considered to be Non-Irritant.
ED DSD (67/548/EEC): Not classified for irritation.
ED CLP (1272/2008/EC)/UN GHS: Not classified for irritation. - Executive summary:
Introduction
The purpose of this study was to determine the eye irritation potential of the test item using the SkinEthic reconstructed Human Corneal Epithelium model (HCE, SkinEthic Laboratories, Lyon, France) after a treatment period of 10 minutes. The test is based on the hypothesis that irritant chemicals are able to penetrate the corneal epithelial tissue and are sufficiently cytotoxic to cause cell death.
Method
The experimental design of the study consists of a test for direct reduction of MTT (3 [4,5 dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) by the test item followed by the main test.
For the main test, triplicate SkinEthic tissues were treated with the test item for 10 minutes. At the end of the exposure period each SkinEthic tissue was rinsed. The rinsed tissues were taken for MTT loading. After MTT-loading the tissues were removed and immersed in isopropanol for extraction of formazan crystals out of the MTT-loaded tissues.
After extraction the absorbency of triplicate aliquots of the extracted MTT solution for each SkinEthic tissue was measured. The optical density was measured at 562 nm (OD562). Data are presented in the form of percentage viability (MTT conversion relative to negative controls).
The mean tissue viability for the test item was compared to the negative control and classified according to the following table:
Criteria for in vitro
interpretation
Prediction
EU DSD
(67/548/EEC)
EU CLP
(1272/2008/EC)
UN GHS
Relative mean tissue
viability≤60%
Irritant
Symbol “Xi”
Risk Phrase
R36 or R41
H318 or H319
Category 1 or 2
H318, H319 or H320
Category 1or 2A or
2B
Relative mean tissue
viability >60%
Non-Irritant
Not classified
for irritation
Not classified
for irritation
Not classified
for irritation
Results
The relative mean viability of the test item treated tissues after a 10 Minute exposure period was 99.7%.
Quality Criterion
The quality criterion required for acceptance of results in the test was satisfied.
Conclusion
According to the study plan followed the test item was considered to be Non-Irritant.
ED DSD (67/548/EEC): Not classified for irritation.
ED CLP (1272/2008/EC)/UN GHS: Not classified for irritation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Although ECHA is providing a lot of online material in your language, part of this page is only in English. More about ECHA’s multilingual practice.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
the-echa-website-uses-cookies
find-out-more-on how-we-use-cookies